The Effects of Vaginal Gestrinone with Histone Deacetylase Inhibitors on Endometriosis-Related Pain and Endometrial Proliferation - A Short Study

Maia Jr H, Clarice Haddad, Junior WS
In: Journal of Clinical Case Studies · 2018 · vol. 3(1) · doi:10.16966/2471-4925.161 · W2791673826
Non-randomised trial OA: diamond CC0
📄 Open PDF View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-14 ⓘ

This study investigated the effects of vaginal valproic acid or resveratrol with vitamin D3, administered vaginally, on deep endometriosis pain in patients treated with gestrinone.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Objective: The present study was designed to investigate the effects of valproic acid or resveratrol, together with vitamin D3 (VITD3) in Pentravan® (PTV) administered vaginally, on deep endometriosis-associated pain in patients undergoing treatment with gestrinone.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (18)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK